Enlivex Therapeutics Ltd. (NASDAQ:ENLV) Sees Large Decrease in Short Interest wkrb13.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wkrb13.com Daily Mail and Mail on Sunday newspapers.
HC Wainwright reaffirmed their buy rating on shares of Enlivex Therapeutics (NASDAQ:ENLV – Free Report) in a report issued on Tuesday morning, Benzinga reports. HC Wainwright currently has a $7.00 target price on the stock. Enlivex Therapeutics Stock Down 3.3 % Enlivex Therapeutics stock opened at $1.45 on Tuesday. Enlivex Therapeutics has a one year […]
HC Wainwright restated their buy rating on shares of Enlivex Therapeutics (NASDAQ:ENLV – Free Report) in a report released on Tuesday, Benzinga reports. The firm currently has a $7.00 target price on the stock. Enlivex Therapeutics Trading Down 3.3 % Shares of ENLV stock opened at $1.45 on Tuesday. Enlivex Therapeutics has a 52-week low […]